The Miami Project to Cure Paralysis, Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Apoptosis, Cancer and Development Laboratory - Equipe labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université de Lyon, Université de Lyon1, Lyon, France.
Cell Death Differ. 2023 Feb;30(2):397-406. doi: 10.1038/s41418-022-01091-z. Epub 2022 Dec 1.
Hallmark pathological features of brain trauma are axonal degeneration and demyelination because myelin-producing oligodendrocytes (OLs) are particularly vulnerable to injury-induced death signals. To reveal mechanisms responsible for this OL loss, we examined a novel class of "death receptors" called dependence receptors (DepRs). DepRs initiate pro-death signals in the absence of their respective ligand(s), yet little is known about their role after injury. Here, we investigated whether the deleted in colorectal cancer (DCC) DepR contributes to OL loss after brain injury. We found that administration of its netrin-1 ligand is sufficient to block OL cell death. We also show that upon acute injury, DCC is upregulated while netrin-1 is downregulated in perilesional tissues. Moreover, after genetically silencing pro-death activity using DCC mutant mice, we observed greater OL survival, greater myelin integrity, and improved motor function. Our findings uncover a novel role for the netrin-1/DCC pathway in regulating OL loss in the traumatically injured brain.
脑创伤的标志性病理特征是轴突变性和脱髓鞘,因为产生髓磷脂的少突胶质细胞(OL)特别容易受到损伤诱导的死亡信号的影响。为了揭示导致 OL 丧失的机制,我们研究了一类称为依赖性受体(DepR)的新型“死亡受体”。DepR 在没有其相应配体的情况下启动促死亡信号,但对其损伤后的作用知之甚少。在这里,我们研究了结肠癌缺失(DCC)DepR 是否有助于脑损伤后的 OL 丧失。我们发现,其 netrin-1 配体的给药足以阻止 OL 细胞死亡。我们还表明,在急性损伤时,DCC 在损伤周围组织中上调,而 netrin-1 下调。此外,使用 DCC 突变小鼠对促死亡活性进行基因沉默后,我们观察到 OL 存活增加、髓鞘完整性增加和运动功能改善。我们的研究结果揭示了 netrin-1/DCC 通路在调节创伤性脑损伤中 OL 丧失中的新作用。